Transplantation of Roxadustat‐preconditioned bone marrow stromal cells improves neurological function recovery through enhancing grafted cell survival in ischemic stroke rats

AIMS: The therapeutic effect of bone marrow stromal cell (BMSC) transplantation for ischemic stroke is limited by its low survival rate. The purpose of this study was to evaluate whether Roxadustat (FG‐4592) pretreatment could promote the survival rate of grafted BMSCs and improve neurological funct...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jiayu, Lin, Xiao, Yao, Chaojie, Bingwa, Lebohang Anesu, Wang, Hao, Lin, Zhongxiao, Jin, Kunlin, Zhuge, Qichuan, Yang, Su
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437235/
https://www.ncbi.nlm.nih.gov/pubmed/35695696
http://dx.doi.org/10.1111/cns.13890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437235/
https://www.ncbi.nlm.nih.gov/pubmed/35695696
http://dx.doi.org/10.1111/cns.13890

Ejemplares similares